entertainment -WSS

entertainment

author：fashion 2025-10-02 18:05:17 - browse：2522

Adam's take main illustration — Molly Ferguson/STAT

Novartis said Monday that it intends to buy MorphoSys for just under $3 billion. The deal will not close. Six months from now, or sooner, Novartis will walk away — slightly embarrassed but otherwise unscathed — happy to pay a small breakup fee to MorphoSys to avoid owning a drug for myelofibrosis that regulators turned away.

MorphoSys will not fare as well from the breakup. Its future, and that of the drug called pelabresib at the center of the deal, will be thrown into limbo.

This is all speculation on my part, but it’s supported by separate conversations with two people familiar with pelabresib and the debate inside Novartis over the MorphoSys acquisition. They requested anonymity to discuss confidential matters.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： Florida Supreme Court upholds state's abortion ban

hotspot

WSS

Overprescribed: High cost isn't America's only drug problem

First Opinion on colorectal cancer screening: letter and response

Washington Commanders' Dan Snyder ordered to pay NFL $60M following investigation

Grand jury probing Trump's efforts to overturn 2020 election did not meet Friday: Sources

Biden White House, tech companies launch new safeguards around emerging AI technology

Study: Black kids more likely to die after surgery than white kids

hotspot

entertainment

entertainment

23andMe had bad news about my health. I wish a person had delivered it

Insurer loopholes limit power of law against surprise medical bills

How to save PrEP access — and even expand it

Oral obesity drug from Viking Therapeutics hits key early target

New air purifier tech could be key to improving indoor air quality

New chart reveals military’s vast involvement in Operation Warp Speed

Malaria cases in Florida and Texas: Here’s what you need to know

Suspects arrested after 3 women attacked on Manhattan's West Side: Police

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Alzheimer's risk factor APOE4 may be a distinct form of the disease

hotspot

U.K. decision on ALS drug has neurologists, advocates up in arms

Study: Black kids more likely to die after surgery than white kids

Bird flu in dairy cattle: New measures to control spread to humans

The biotech scorecard for the 2nd quarter: 12 industry events to watch

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

Gut bacteria may contribute to kidney autoimmunity, study finds

hotspot

focus

focus

focus